Search - tctmd.com

Displaying 701 - 720 of 832

Sort: Relevancy | Date

News Daily News

La Revascularización Híbrida Sigue Sin estar Disponible el Hospitales de EE.UU. Aunque están Probados sus Perfiles de Seguridad y Eficacia

L.A. McKeown

August 07, 2014

News Daily News

Hybrid Revascularization Still Not Widely Available in US Hospitals Even With Proven Efficacy, Safety

L.A. McKeown

August 07, 2014

News Daily News

联合血运重建有望给糖尿病患者带来福音

L.A. McKeown

July 24, 2014

News Daily News

Hybrid Revascularization a Promising Option for Diabetic Patients

L.A. McKeown

July 24, 2014

News Daily News

Una Estrategia de Anticoagulación Potente con Reversión Rápida Post-PCI parece Segura y Efectiva

L.A. McKeown

July 03, 2014

News Daily News

Strategy of Potent Anticoagulation with Rapid Post-PCI Reversal Appears Safe, Effective

L.A. McKeown

July 03, 2014

News Daily News

Personal Radiation Monitor Registers ‘Real Time’ Operator Exposure in Cath Lab

L.A. McKeown

May 30, 2014

News Daily News

Meta-analysis: Bone Marrow Stem Cell Research Riddled with Discrepancies

L.A. McKeown

May 13, 2014

News Daily News

ROCKET AF Substudy: Rivaroxaban Safe, Effective in East Asian Patients

L.A. McKeown

April 29, 2014

News Daily News

PLATO Substudy: Ticagrelor Reduces Mortality in NSTE-ACS Patients Regardless of Revascularization

L.A. McKeown

April 25, 2014

News Daily News

ROCKET AF Analysis Isolates Predictors of Intracranial Hemorrhage in A-fib Population

L.A. McKeown

April 22, 2014

News Daily News

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

L.A. McKeown

April 11, 2014

News Daily News

El Antidiabético Aleglitazar No Logra Reducir los Resultados Isquémicos de Diabéticos con SCA de Reciente Aparición

L.A. McKeown

April 11, 2014

News Daily News

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

L.A. McKeown

April 11, 2014

News Conference News ACC 2014

Massachusetts Study Sees Steep Declines in Revascularization Over Last Decade

L.A. McKeown

March 30, 2014

News Daily News

Mortality Benefit with ACE Inhibitors in Nonobstructive CAD

L.A. McKeown

March 20, 2014

News Daily News

Beneficio sobre la Mortalidad con Inhibidores de la ECA en la EAC No Obstructiva

L.A. McKeown

March 20, 2014

News Daily News

NCDR Data Show Post-PCI Transfusion Linked with Poor Outcomes

L.A. McKeown

February 26, 2014

News Daily News

Los Datos del NCDE Revelan que las Transfusiones post-PCI acarrean Malos Resultados

L.A. McKeown

February 26, 2014

News Daily News

Las Hemorragias son Frecuentes aunque No Suelen hacerse Públicas en Pacientes SCA a Tratamiento Antiplaquetario

L.A. McKeown

February 06, 2014

Advertisement

La Revascularización Híbrida Sigue Sin estar Disponible el Hospitales de EE.UU. Aunque están Probados sus Perfiles de Seguridad y Eficacia

Hybrid Revascularization Still Not Widely Available in US Hospitals Even With Proven Efficacy, Safety

联合血运重建有望给糖尿病患者带来福音

Hybrid Revascularization a Promising Option for Diabetic Patients

Una Estrategia de Anticoagulación Potente con Reversión Rápida Post-PCI parece Segura y Efectiva

Strategy of Potent Anticoagulation with Rapid Post-PCI Reversal Appears Safe, Effective

Personal Radiation Monitor Registers ‘Real Time’ Operator Exposure in Cath Lab

Meta-analysis: Bone Marrow Stem Cell Research Riddled with Discrepancies

ROCKET AF Substudy: Rivaroxaban Safe, Effective in East Asian Patients

PLATO Substudy: Ticagrelor Reduces Mortality in NSTE-ACS Patients Regardless of Revascularization

ROCKET AF Analysis Isolates Predictors of Intracranial Hemorrhage in A-fib Population

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

El Antidiabético Aleglitazar No Logra Reducir los Resultados Isquémicos de Diabéticos con SCA de Reciente Aparición

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

Massachusetts Study Sees Steep Declines in Revascularization Over Last Decade

Mortality Benefit with ACE Inhibitors in Nonobstructive CAD

Beneficio sobre la Mortalidad con Inhibidores de la ECA en la EAC No Obstructiva

NCDR Data Show Post-PCI Transfusion Linked with Poor Outcomes

Los Datos del NCDE Revelan que las Transfusiones post-PCI acarrean Malos Resultados

Las Hemorragias son Frecuentes aunque No Suelen hacerse Públicas en Pacientes SCA a Tratamiento Antiplaquetario

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content